Published in J Inherit Metab Dis on August 01, 2006
Neonatal neuroimaging findings in inborn errors of metabolism. J Magn Reson Imaging (2012) 0.86
Recent advances in newborn screening. J Inherit Metab Dis (2007) 0.86
Description of the mutations in 15 subjects with variant forms of maple syrup urine disease. J Inherit Metab Dis (2007) 0.84
Clinical and biochemical profiles of maple syrup urine disease in malaysian children. JIMD Rep (2011) 0.81
Recall rate and positive predictive value of MSUD screening is not influenced by hydroxyproline. Eur J Pediatr (2008) 0.77
Clinical and neuroimaging features as diagnostic guides in neonatal neurology diseases with cerebellar involvement. Cerebellum Ataxias (2016) 0.75
Plasma amino acid and urine organic acid profiles of Filipino patients with maple syrup urine disease (MSUD) and correlation with their neurologic features. Mol Genet Metab Rep (2016) 0.75
Challenges in the management of patients with maple syrup urine disease diagnosed by newborn screening in a developing country. J Community Genet (2016) 0.75
Treatment strategies for acute metabolic disorders in neonates. Sudan J Paediatr (2011) 0.75
Neurometabolic diseases of childhood. Pediatr Radiol (2015) 0.75
Intellectual outcome in children with maple syrup urine disease. J Pediatr (1991) 1.26
Outcome of maple syrup urine disease. Arch Dis Child (1982) 1.20
Dialysis in neonates with inborn errors of metabolism. Nephrol Dial Transplant (1999) 1.16
Impact of longitudinal plasma leucine levels on the intellectual outcome in patients with classic MSUD. Pediatr Res (2005) 1.05
Diagnosis of MSUD by newborn screening allows early intervention without extraneous detoxification. Mol Genet Metab (2005) 0.93
Intellectual performance of children with maple syrup urine disease. Eur J Pediatr (1993) 0.93
Treatment outcome of maple syrup urine disease. Acta Paediatr Jpn (1988) 0.86
Continuous venovenous haemodiafiltration in the acute phase of neonatal maple syrup urine disease. J Inherit Metab Dis (1997) 0.81
Treatment recommendations in long-chain fatty acid oxidation defects: consensus from a workshop. J Inherit Metab Dis (2009) 1.58
Betaine in the treatment of homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency. Eur J Pediatr (1984) 1.47
Hydrocephalus internus in two patients with 5,10-methylenetetrahydrofolate reductase deficiency. Neuropediatrics (2000) 1.44
Glutaric aciduria type II: report on a previously undescribed metabolic disorder. Clin Chim Acta (1976) 1.44
The putative glucose 6-phosphate translocase gene is mutated in essentially all cases of glycogen storage disease type I non-a. Eur J Hum Genet (1999) 1.42
Proton MR spectroscopy of the lumbar spine in patients with glycogen storage disease type Ib. J Magn Reson Imaging (2001) 1.37
Management and outcome in 75 individuals with long-chain fatty acid oxidation defects: results from a workshop. J Inherit Metab Dis (2009) 1.30
Prevalence of coeliac disease in diabetic children and adolescents. A multicentre study. Eur J Pediatr (1988) 1.22
Demyelination and decreased S-adenosylmethionine in 5,10-methylenetetrahydrofolate reductase deficiency. Neurology (1988) 1.15
Changes in blood carnitine and acylcarnitine profiles of very long-chain acyl-CoA dehydrogenase-deficient mice subjected to stress. Eur J Clin Invest (2004) 1.13
DNA haplotype analysis at the phenylalanine hydroxylase locus in the Turkish population. Hum Genet (1989) 1.12
Clinical and biochemical characteristics of congenital disorder of glycosylation type Ic, the first recognized endoplasmic reticulum defect in N-glycan synthesis. Ann Neurol (2000) 1.09
Purification and characterization of an alpha-methylacyl-CoA racemase from human liver. Eur J Biochem (1995) 1.09
Standardized method for high-resolution 1H-NMR of cerebrospinal fluid. Clin Chem (1995) 1.08
Rapid diagnosis of maple syrup urine disease (branched chain ketoaciduria) by micro-enzyme assay in leukocytes and fibroblasts. Clin Chim Acta (1973) 1.07
Purification and properties of an alpha-methylacyl-CoA racemase from rat liver. Eur J Biochem (1994) 1.07
Social outcome in adults with maple syrup urine disease (MSUD). J Inherit Metab Dis (2007) 1.07
Regional blood flow to the lymph node during the immune response. Lymphology (1976) 1.06
Propionic acidemia: neonatal versus selective metabolic screening. J Inherit Metab Dis (2011) 1.05
Multiple acyl-Co A dehydrogenation deficiency (MADD) in a boy with nonketotic hypoglycemia, hepatomegaly, muscle hypotonia and cardiomyopathy. Detection of N-isovalerylglutamic acid and its monoamide. Helv Paediatr Acta (1983) 1.05
Variant maple syrup urine disease (MSUD)--the entire spectrum. J Inherit Metab Dis (2006) 1.04
Lethal infantile mitochondrial disease with isolated complex I deficiency in fibroblasts but with combined complex I and IV deficiencies in muscle. Neurology (1996) 1.04
Pregnancy in a woman with maple syrup urine disease. J Inherit Metab Dis (1998) 1.03
Evidence for impaired gluconeogenesis in very long-chain acyl-CoA dehydrogenase-deficient mice. Horm Metab Res (2006) 1.02
Alpha-ketoadipic aciduria: degradation studies with fibroblasts,. Clin Chim Acta (1975) 1.02
Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease. Mol Genet Metab (2004) 1.02
Maple syrup urine disease: metabolic decompensation monitored by proton magnetic resonance imaging and spectroscopy. Ann Neurol (1993) 1.01
The clinical spectrum of mitochondrial disease in 75 pediatric patients. Clin Pediatr (Phila) (2003) 1.00
A patient with alpha-ketoadipic and alpha-aminoadipic aciduria. J Inherit Metab Dis (1984) 0.99
Alpha-ketoadipic aciduria, a new inborn error of lysine metabolism; biochemical studies. Clin Chim Acta (1975) 0.99
Severe neurological crisis in a patient with hereditary tyrosinaemia type I after interruption of NTBC treatment. J Inherit Metab Dis (2008) 0.99
Branched-chain L-amino acid metabolism in classical maple syrup urine disease after orthotopic liver transplantation. J Inherit Metab Dis (2000) 0.97
Antibiotic therapy for improvement of metabolic control in methylmalonic aciduria. J Pediatr (1990) 0.97
[Model project for updating neonatal screening in Bavaria: concept and initial results]. Gesundheitswesen (2000) 0.96
Maple syrup urine disease: analysis of branched chain ketoacid decarboxylation in cultured fibroblasts. Pediatr Res (1975) 0.96
Simple method for the routine determination of betaine and N,N-dimethylglycine in blood and urine. Clin Chem (1998) 0.95
Is demyelination a feature of maple syrup urine disease? Pediatr Neurol (1994) 0.94
Cell cycle parameters in radiation sensitive strains of Saccharomyces cerevisiae. Mol Gen Genet (1984) 0.94
Diagnosis of MSUD by newborn screening allows early intervention without extraneous detoxification. Mol Genet Metab (2005) 0.93
Mutation analysis in 54 propionic acidemia patients. J Inherit Metab Dis (2011) 0.93
Pitfalls in measuring plasma cholesterol in the Smith-Lemli-Opitz syndrome. Clin Chem (1997) 0.93
Intellectual performance of children with maple syrup urine disease. Eur J Pediatr (1993) 0.93
Positive effect of a simplified diet on blood phenylalanine control in different phenylketonuria variants, characterized by newborn BH4 loading test and PAH analysis. Mol Genet Metab (2012) 0.93
Proton magnetic resonance spectroscopy reflects metabolic decompensation in maple syrup urine disease. Pediatr Radiol (1995) 0.90
Significance of L-alloisoleucine in plasma for diagnosis of maple syrup urine disease. Clin Chem (1999) 0.90
Hematological abnormalities and cholestatic liver disease in two patients with mevalonate kinase deficiency. Am J Med Genet (1998) 0.90
Carnitine supplementation induces long-chain acylcarnitine production--studies in the VLCAD-deficient mouse. J Inherit Metab Dis (2006) 0.89
Beta cell nesidioblastosis. Eur J Pediatr (1978) 0.89
Development of height and weight in children with diabetes mellitus: report on two prospective multicentre studies, one cross-sectional, one longitudinal. Eur J Pediatr (1992) 0.88
Decreased ganglioside neuraminidase activity in fibroblasts from mucopolysaccharidosis patients. Inhibition of the activity in vitro by sulfated glycosaminoglycans and other compounds. Biochim Biophys Acta (1983) 0.88
Diagnostic work-up and management of patients with isolated methylmalonic acidurias in European metabolic centres. J Inherit Metab Dis (2008) 0.88
Identification of four novel mutations in severe methylenetetrahydrofolate reductase deficiency. Eur J Hum Genet (1998) 0.88
Acute neuronopathic Gaucher disease complicated by fatal gastrointestinal bleeding. Neuropediatrics (2006) 0.87
Metabolism of branched-chain amino acids in maple syrup urine disease. Eur J Pediatr (1997) 0.87
Normal clinical outcome in untreated subjects with mild hyperphenylalaninemia. Pediatr Res (2001) 0.87
Prenatal diagnosis and confirmation of infantile sialic acid storage disease. Prenat Diagn (1987) 0.87
Defects in the mitochondrial energy metabolism outside the respiratory chain and the pyruvate dehydrogenase complex. Mol Cell Biochem (1997) 0.87
HLA and Wolfram (DIDMOAD) syndrome. Lancet (1983) 0.87
Clinical differences in patients with mitochondriocytopathies due to nuclear versus mitochondrial DNA mutations. Hum Mutat (2000) 0.87
Dissection of biochemical borderline phenotypes in carriers and genetic variants of medium-chain acyl-CoA dehyrogenase deficiency: implications for newborn screening [corrected]. Clin Genet (2009) 0.87
Analysis of the fatty acid composition of erythrocyte phospholipids by a base catalysed transesterification method--prevention of formation of dimethylacetals. Clin Chim Acta (1988) 0.86
N-Acetylneuraminic acid storage disease. Hum Genet (1985) 0.86
Studies on the optimal cooling rate for freezing human diploid fibroblasts. Exp Cell Res (1973) 0.86
Defective lysosomal release of glycoprotein-derived sialic acid in fibroblasts from patients with sialic acid storage disease. Biochem J (1988) 0.86
Familial lysosomal storage disease with generalized vacuolization and sialic aciduria. Sporadic Salla disease. Neuropediatrics (1985) 0.86
Increased manganese content and reduced arginase activity in erythrocytes of a patient with prolidase deficiency (iminodipeptiduria). Eur J Pediatr (1986) 0.85
Secondary respiratory chain defect in a boy with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: possible diagnostic pitfalls. Eur J Pediatr (2000) 0.85
A familial progressive neurodegenerative disease with 2-oxoglutaric aciduria. Eur J Pediatr (1982) 0.85
Importance of mitochondrial transmembrane processes in human mitochondriopathies. J Bioenerg Biomembr (1996) 0.85
beta-Trace protein in human cerebrospinal fluid: a diagnostic marker for N-glycosylation defects in brain. Biochim Biophys Acta (1999) 0.85
Deficiency of the voltage-dependent anion channel: a novel cause of mitochondriopathy. Pediatr Res (1996) 0.85
Structural white matter changes in adolescents and young adults with maple syrup urine disease. J Inherit Metab Dis (2013) 0.85
Multiple acyl-CoA dehydrogenation deficiency (glutaric aciduria type II), congenital polycystic kidneys, and symmetric warty dysplasia of the cerebral cortex in two brothers. I. Clinical, metabolical, and biochemical findings. Eur J Pediatr (1982) 0.85
Genetic counselling and prenatal diagnosis in disorders of the mitochondrial energy metabolism. J Inherit Metab Dis (1996) 0.84
White matter abnormalities in patients with treated hyperphenylalaninaemia: magnetic resonance relaxometry and proton spectroscopy findings. Eur J Pediatr (1993) 0.84
Description of the mutations in 15 subjects with variant forms of maple syrup urine disease. J Inherit Metab Dis (2007) 0.84
Liver transplantation in two cases of propionic acidaemia. J Inherit Metab Dis (1995) 0.84
Isolated (biotin-resistant) 3-methylcrotonyl-CoA carboxylase deficiency: four sibs devoid of pathology. J Inherit Metab Dis (1995) 0.84
Clinical heterogeneity in respiratory chain complex III deficiency in childhood. J Neurol Sci (1997) 0.84
Molecular genetic characterization and urinary excretion pattern of metabolites in two families with MCAD deficiency due to compound heterozygosity with a 13 base pair insertion in one allele. J Inherit Metab Dis (1994) 0.84
Metabolic phenotypes of phenylketonuria. Kinetic and molecular evaluation of the Blaskovics protein loading test. J Inherit Metab Dis (2009) 0.83
Metabolic stroke in isolated 3-methylcrotonyl-CoA carboxylase deficiency. Eur J Pediatr (1999) 0.83
Nerve cell lesions caused by 3-hydroxyglutaric acid: a possible mechanism for neurodegeneration in glutaric acidaemia I. J Inherit Metab Dis (1997) 0.83
Whole-body L-leucine oxidation in patients with variant form of maple syrup urine disease. Pediatr Res (2001) 0.82
Granulocyte and granulocyte-macrophage colony-stimulating factors for treatment of neutropenia in glycogen storage disease type Ib. J Pediatr (1991) 0.82
Prenatal detection of defects in propionate metabolism. Clin Chim Acta (1980) 0.82
[Diseases caused by genetic defects in lysosomal muco-polysaccharide-catabolism. Mucopolysaccharidoses]. Dtsch Med Wochenschr (1974) 0.82
3-Methylglutaconic and 3-methylglutaric aciduria in a patient with suspected 3-methylglutaconyl-CoA hydratase deficiency. Eur J Pediatr (1985) 0.82
Association of malonyl-CoA decarboxylase deficiency and heterozygote state for haemoglobin C disease. J Inherit Metab Dis (1994) 0.82
Prenatal diagnosis for methylenetetrahydrofolate reductase deficiency. J Pediatr (1983) 0.82
Maple syrup urine disease: mutation analysis in Turkish patients. J Inherit Metab Dis (2002) 0.81
Cardiomyopathy and pericardial effusion in infancy point to a fatty acid b-oxidation defect after exclusion of an underlying infection. Pediatr Cardiol (2002) 0.81
Novel mutations in patients with fructose-1,6-bisphosphatase deficiency. J Inherit Metab Dis (1999) 0.81
Enzymatic method for determination of branched-chain amino acid aminotransferase activity. Anal Biochem (1995) 0.81
Intracellular levels and metabolism of leucine and alpha-ketoisocaproate in normal and maple syrup urine disease fibroblasts. Biochem Med (1984) 0.81
Analysis of concentration and (13)C enrichment of D-galactose in human plasma. Clin Chem (2000) 0.81
Recurrent acroparaesthesia during febrile infections. Lancet (2004) 0.80
Maple-syrup-urine disease. N Engl J Med (1983) 0.80
Purification and some properties of a kininogenase from human plasma activated by surface contact. Hoppe Seylers Z Physiol Chem (1972) 0.80
Glycogenosis type Ib complicated by severe granulocytopenia resembling inherited neutropenia. Eur J Pediatr (1981) 0.80